Urology News and Research RSS Feed - Urology News and Research

Urology is the field of medicine that focuses on the urinary tracts of males and females, and on the reproductive system of males. In men, the urinary system overlaps with the reproductive system, and in women the urinary tract opens into the vulva. In both sexes, the urinary and reproductive tracts are close together, and disorders of one often affect the other. The organs covered by urology include the kidneys, ureters, urinary bladder, urethra, and the male reproductive organs (testes, epididymis, vas deferens, seminal vesicles, prostate and penis).
Further Reading
Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Arno Therapeutics, Inc., a clinical stage biopharmaceutical company primarily focused on the development of oncology therapeutics, today announced that data from a preclinical study demonstrate its histone-deacetylase (HDAC) inhibitor AR-42 in combination with cisplatin has a synergistic anti-tumor effect in bladder cancer models. [More]
Mayo Clinic Center for Tuberculosis introduces new medical journal

Mayo Clinic Center for Tuberculosis introduces new medical journal

The Mayo Clinic Center for Tuberculosis, a regional training and consultation center at Mayo Clinic's campus in Rochester, Minn, is today launching a new medical journal, the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. [More]
ISSM selects Elsevier to publish three prestigious journals

ISSM selects Elsevier to publish three prestigious journals

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced that it has been selected by the International Society for Sexual Medicine (ISSM) to publish its flagship journal, The Journal of Sexual Medicine, as well as Sexual Medicine Reviews and open access journal Sexual Medicine, as of January 2016. [More]
Cancer-specific mortality lower in Asian Americans than non-Hispanic whites, shows study

Cancer-specific mortality lower in Asian Americans than non-Hispanic whites, shows study

Numerous studies have documented racial differences in deaths from cancer among non-Hispanic whites and African Americans, but little has been known about survival outcomes for Asian Americans who have been diagnosed with cancer, until now. [More]
Myriad announces Prolaris® test biopsy results from EMPATHY-P study at European Association of Urology annual meeting

Myriad announces Prolaris® test biopsy results from EMPATHY-P study at European Association of Urology annual meeting

Myriad Genetics, Inc. (NASDAQ: MYGN) today announced that results from the EMPATHY-P clinical study of Prolaris in patients newly diagnosed with prostate cancer will be highlighted at the 30th Annual Congress of the European Association of Urology. [More]
Implementation of video-based decision aids influences care decisions in urology

Implementation of video-based decision aids influences care decisions in urology

After Group Health Cooperative implemented video-based decision aids for men with two common prostate conditions, rates of elective surgery for benign prostatic hyperplasia (BPH) and rates of active treatment for localized prostate cancer declined over six months. [More]
Study reveals how Grhl2 plays a role in kidney function

Study reveals how Grhl2 plays a role in kidney function

The kidney carries out vital functions by continuously filtering the blood and excreting waste products into the urine. This is achieved by a complex system of tubules which transports the urine and regulates its composition. [More]
Duke researchers identify factors that correlate with repeat ER visits for kidney stones

Duke researchers identify factors that correlate with repeat ER visits for kidney stones

One in nine patients released from the emergency department after treatment for a kidney stone will face a repeat visit, according to findings by Duke Medicine researchers. [More]
AdMeTech Foundation announces launch of statewide prostate cancer awareness program

AdMeTech Foundation announces launch of statewide prostate cancer awareness program

AdMeTech Foundation today announced the launch of a statewide prostate cancer education and awareness campaign supported by the Massachusetts Department of Public Health. [More]
Cost of care for benign prostate hyperplasia measured for the first time

Cost of care for benign prostate hyperplasia measured for the first time

UCLA researchers have for the first time described cost across an entire care process for a common condition called benign prostate hyperplasia (BPH) using time-driven activity-based costing. They found a 400 percent discrepancy between the least and most expensive ways to treat the condition. [More]
MDC scientists identify new molecular signaling pathway that regulates placental development

MDC scientists identify new molecular signaling pathway that regulates placental development

During pregnancy, the mother supplies the fetus with nutrients and oxygen via the placenta. If placental development is impaired, this may lead to growth disorders of the embryo or to life-threatening diseases of the mother such as preeclampsia, a serious condition involving high blood pressure and increased urinary protein excretion. [More]
Depression symptoms under-recognized in African-American cancer patients

Depression symptoms under-recognized in African-American cancer patients

Case Western Reserve University nurse scientist Amy Zhang, who has long examined quality-of-life issues in cancer patients, wondered whether depression in African-American cancer patients has been under-recognized for treatment. [More]
Hitachi Aloka Medical announces release of Ultrasound Bone Densitometry System at ECR 2015

Hitachi Aloka Medical announces release of Ultrasound Bone Densitometry System at ECR 2015

Mr Minoru Yoshizumi, President of Hitachi Aloka Medical Ltd., Tokyo, Japan, is pleased to announce the release of EggQus, an extraordinary compact, portable Ultrasound Bone Densitometry System at the European Radiology Congress. Delegates will have the opportunity to see and test EggQus at the Hitachi Medical Systems booth 323, Expo C. [More]
New study assesses suicide risks in older, white males with advanced bladder cancer

New study assesses suicide risks in older, white males with advanced bladder cancer

Older, single white males with advanced bladder cancer have the highest suicide risk among those with other cancers of the male genitals and urinary system, researchers report. [More]
Endo International’s revenues increase $800 million to 37% in fourth quarter 2014

Endo International’s revenues increase $800 million to 37% in fourth quarter 2014

Endo International plc today reported fourth quarter 2014 revenues of $800 million, an increase of 37 percent compared to fourth quarter 2013 revenues of $585 million, including new product revenue from 2014 strategic M&A transactions. [More]
Taiho announces submission of TAS-102 MAA to EMA for treatment of mCRC

Taiho announces submission of TAS-102 MAA to EMA for treatment of mCRC

Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho Pharmaceutical Co., Ltd., announced that it has submitted a Marketing Authorisation Application to the European Medicines Agency for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug intended for use in the treatment of refractory metastatic colorectal cancer (mCRC). [More]
Study reports 10% reduction in overall C-section births in Portugal

Study reports 10% reduction in overall C-section births in Portugal

A new study reports a significant decline in the rate of cesarean section (C-section) births in Portugal. Findings published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, indicate a 10% reduction in overall C-section rates between 2009 and 2014, with a 14% reduction in state-hospitals during the same time period. [More]
Patients who receive chemotherapy after bladder cancer surgery demonstrate 30% lower risk of death

Patients who receive chemotherapy after bladder cancer surgery demonstrate 30% lower risk of death

Patients that received chemotherapy after bladder cancer surgery demonstrated an approximately 30% lower risk of death than those that underwent surgery alone, according to an analysis to be presented by researchers at the Icahn School of Medicine at Mount Sinai at the 2015 Genitourinary Cancers Symposium. [More]
FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, today announced the approval of LILETTA (levonorgestrel-releasing intrauterine system) by the U.S. Food and Drug Administration for use by women to prevent pregnancy for up to three years. [More]
Frailty assessment test can accurately predict complications after major operation

Frailty assessment test can accurately predict complications after major operation

Frailty has been used to predict how well a patient may recover from a major operation. Because frailty assessments are not routinely utilized in busy surgical practices, surgeons at Emory University School of Medicine in Atlanta have discovered that a short, approximately one-minute assessment can accurately determine how likely a patient is to have complications after an operation. [More]
Advertisement
Advertisement